Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer

NCT07645391 is registered in ClinicalTrials.gov with University of Michigan Rogel Cancer Center as lead sponsor.

NCT NCT07645391
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07645391 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeted Early Detection Program in Men at High Genetic Risk for Prostate Cancer
Lead sponsor
University of Michigan Rogel Cancer Center
Phase
Observational
Overall status
Recruiting
Start date
January 1, 2017
Completion date
January 31, 2030
Enrollment
200 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

prostate carcinoma